Q32 Bio Inc QTTB 深 滬
已收盤 06-18 16:00:00 美东时间
11.90
-1.010
-7.82%
華盛通- 最 高13.37
- 今 開13.15
- 成交量 40.78万股
- 最 低 11.70
- 昨 收 12.91
- 總市值 2.02亿
- 52周最高 14.8499
- 市盈率 靜 4.91
- 換手率 2.40%
- 52周最低 1.345
- 委 比 70.47%
- 總股本 1695.64万
- 歷史最高 572.40
- 量 比 1.13
- 振 幅 12.94%
- 歷史最低 1.345
- 每 手 1
- 風險率 2.70%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Why Is Q32 Bio Stock Gaining Friday?
Q32 Bio ($QTTB) jumps in premarket trading after securing a $55M private placement to fund its autoimmune pipeline. Read more.
05-29 22:10
美股牛股 | VTIX飙升46%，获美国空军SBIR项目资金支持；360数科大涨25%
VTIX飙升46%，获美国空军SBIR项目资金支持；APPS大涨38%，财报强劲，美银称其增长前景清晰；360数科大涨25%，用户规模稳步扩容，信贷投放有所收缩>>
05-28 19:22
Q32 Bio Inks Securities Purchase Agreement With New, Current Institutional Investors For ~$55M Private Placement Of Common Stock, Pre-Funded Warrants
Q32 Bio Inc. (NASDAQ:QTTB) ("Q32 Bio" or "Company"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other autoimmune and inflammatory diseases, today
05-27 20:04
Cantor Fitzgerald Initiates Coverage On Q32 Bio with Overweight Rating
Cantor Fitzgerald initiates coverage on Q32 Bio (NASDAQ:QTTB) with a Overweight rating.
05-18 23:19
美股大行评级 | Stifel上调Lumentum控股目标价从800美元升至1100美元；Pinterest、先进能源工业、安森美半导体、莱迪思半导体、V2X等获多家大行上调目标价
今日重点评级关注：Piper Sandler：维持Aclaris Therapeutics"超配"评级，目标价从7美元升至11美元；Evercore ISI集团：维持BioMarin Pharmaceutical"跑赢大市"评级，目标价从110美元升至120美元
05-06 11:29
HC Wainwright & Co. Reiterates Buy on Q32 Bio, Maintains $13 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates Q32 Bio (NASDAQ:QTTB) with a Buy and maintains $13 price target.
05-06 00:14
Earnings Scheduled For May 5, 2026
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
Q32 Bio Q1 EPS $(0.54) Beats $(0.68) Estimate
Q32 Bio (NASDAQ:QTTB) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.68) by 20.59 percent. This is a 40 percent increase over losses of $(0.90) per share from the same
05-05 19:09
Why Organon Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Organon & Co (OGN) jumped 14.8% in pre-market trading as Sun Pharma agreed to acquire the company for $11.75 billion, $2 higher than current price.
04-27 16:45
美股夜盘 | Homology Medicines, Inc.跌20.58%，最新股价4.94美元
Homology Medicines, Inc.跌20.58%，报4.94美元
04-27 10:01
